Results 51 to 60 of about 456 (124)

Architecture of the dynamic fungal cell wall

open access: yes, 2023
The fungal cell wall is essential for growth and survival, and is a key target for antifungal drugs and the immune system. The cell wall must be robust but flexible, protective and shielding yet porous to nutrients and membrane vesicles and receptive to ...
Gow, NAR, Lenardon, MD
core   +1 more source

The Significance of Mono‐ and Dual‐Effective Agents in the Development of New Antifungal Strategies

open access: yesChemical Biology &Drug Design, Volume 105, Issue 1, January 2025.
The future of treating challenging fungal infections lies in novel therapies targeting new antifungal targets, overcoming resistance mechanisms, and exploring innovative dual inhibitors. ABSTRACT Invasive fungal infections (IFIs) pose significant challenges in clinical settings, particularly due to their high morbidity and mortality rates.
Cengiz Zobi, Oztekin Algul
wiley   +1 more source

Multidrug resistance mechanisms and therapeutic strategies in Candida auris [PDF]

open access: yes
In recent years, Candida auris has emerged as a formidable global health threat due to its multidrug resistance, high transmissibility in healthcare settings, and diagnostic challenges. Unlike most Candida species, C. auris can colonize the skin, persist
Alkaabi, Sara
core   +2 more sources

Predictors for prolonged hospital stay solely to complete intravenous antifungal treatment in patients with candidemia: Results from the ECMM candida III multinational European observational cohort study [PDF]

open access: yes, 2023
Background To date, azoles represent the only viable option for oral treatment of invasive Candida infections, while rates of azole resistance among non-albicans Candida spp. continue to increase.
Alastruey-Izquierdo, Ana   +53 more
core   +2 more sources

Virulence traits and novel drug delivery strategies for mucormycosis post-COVID-19: a comprehensive review [PDF]

open access: yes, 2023
The outbreak of a fatal black fungus infection after the resurgence of the cadaverous COVID-19 has exhorted scientists worldwide to develop a nutshell by repurposing or designing new formulations to address the crisis.
A. Sophia   +22 more
core   +1 more source

Estudio de la resistencia a los antifúngicos en hongos patógenos humanos [PDF]

open access: yes, 2019
Las mejoras en el diagnóstico, el tratamiento y el cuidado de pacientes inmunodeprimidos han incrementado su tasa de supervivencia, pero también han dado lugar al aumento progresivo de otras enfermedades, como las infecciones fúngicas invasoras.
Rivero Menéndez, Olga
core   +1 more source

Action Mechanisms of Medicinal Plant Components as Antimycosis: A Literature Review [PDF]

open access: yes
Mycosis poses a significant threat to global health, particularly in immune-compromised individuals, and the rise of antifungal resistance has further complicated their treatment.
Abusalim, Ghadah S.   +3 more
core   +2 more sources

Septic arthritis as breakthrough invasive fusariosis after cord blood transplantation [PDF]

open access: yes
A 63-year-old male received a third allogeneic hematopoietic stem cell transplantation with voriconazole prophylaxis for relapsed acute myeloid leukemia.
Ando, Koji   +16 more
core   +1 more source

Candida Auris Features and its Treatment: Global Emergency [PDF]

open access: yes
Fungal pathogen Candida auris was identified in 2009, in Japan. Currently, it is identified in 5 continents, in more than 40 countries. Therefore, it is nowadays defined as critical priority pathogen.
Durán, Nelson   +2 more
core   +2 more sources

Home - About - Disclaimer - Privacy